Systemic corticosteroids in critical illness: an evidence-based framework for clinical decision-making
European Journal of Clinical Pharmacology · 2026-11 · 82 (11)
DOI: 10.1007/s00228-026-04211-7 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift European Journal of Clinical Pharmacology, online erschienen am 04.11.2026. Verfasst von Yu-Wen Chang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan. Hauptthemen laut MEDLINE: Critical Illness, Respiratory Distress Syndrome, Adrenal Cortex Hormones, Shock, Septic. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Purpose
Systemic corticosteroids are pivotal in managing inflammation-driven critical illnesses, yet bedside translation remains inconsistent. This systematic review establishes an evidence-based framework for clinical decision-making by horizontally synthesizing contemporary evidence across severe community-acquired pneumonia (sCAP), acute respiratory distress syndrome (ARDS), and septic shock.
Methods
A systematic electronic search was conducted across PubMed, EMBASE, and the Cochrane Library up to early 2026. Peer-reviewed randomized controlled trials (RCTs), systematic reviews, and meta-analyses published in English were eligible. Data regarding population characteristics, dosing regimens, initiation timing, duration, and safety profiles were independently extracted and qualitatively synthesized.
Results
Landmark trials define context-dependent efficacy: early hydrocortisone continuous infusion significantly reduces 28-day mortality in sCAP (CAPE COD), while a 10-day dexamethasone regimen improves ventilator-free days and survival in moderate-to-severe ARDS (DEXA-ARDS). In septic shock, early hydrocortisone-fludrocortisone combination accelerates shock resolution and lowers 90-day mortality (APROCCHS). These outcomes align with distinct pharmacological profiles: hydrocortisone provides dual glucocorticoid/mineralocorticoid activity to restore vascular tone, whereas dexamethasone exerts potent transrepression of proinflammatory transcription factors. To mitigate steroid-induced harm, protocolized safety targets are essential, including maintaining blood glucose at 140–180 mg/dL and actively monitoring for secondary infections.
Conclusion
Corticosteroids do not exert a uniform class effect. Bedside success requires personalized, protocolized regimens optimized by scenario-specific timing, dosing, and proactive adverse-event monitoring.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan.
- Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung City, 833401, Taiwan.
- Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung, Taiwan.
- Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Kaohsiung Municipal Fong Shan Hospital-Under the management of Chang Gung Medical Foundation, Kaohsiung, Taiwan.
- Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung City, 833401, Taiwan. jelly@cgmh.org.tw.
- Department of Respiratory Therapy, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan. jelly@cgmh.org.tw.
ORCID-Profile: Kuo-Tung Huang
Zitieren
APA
Chang, Y. W., Chung, C. F., Lee, S. H., Tsai, M. Y., Chang, Y. P., Wu, C. C., & Huang, K. T. (2026). Systemic corticosteroids in critical illness: an evidence-based framework for clinical decision-making. European Journal of Clinical Pharmacology, 82(11). https://doi.org/10.1007/s00228-026-04211-7
Vancouver
Chang YW, Chung CF, Lee SH, Tsai MY, Chang YP, Wu CC, et al. Systemic corticosteroids in critical illness: an evidence-based framework for clinical decision-making. European Journal of Clinical Pharmacology. 2026;82(11). doi:10.1007/s00228-026-04211-7
BibTeX
@article{Chang2026,
author = {Chang, Yu-Wen and Chung, Chun-Fu and Lee, Suey-Haur and Tsai, Meng-Yun and Chang, Yu-Ping and Wu, Cheng-Chih and Huang, Kuo-Tung},
title = {Systemic corticosteroids in critical illness: an evidence-based framework for clinical decision-making},
journal = {European Journal of Clinical Pharmacology},
year = {2026},
volume = {82},
number = {11},
doi = {10.1007/s00228-026-04211-7}
}
EUVIMED